A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer
NCT03271073
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Apatinib
Sponsor
Beijing Friendship Hospital